Eveline P. Mauser‐Bunschoten

The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and Reliability

Bert Verbruggen, I.R.O. Nováková, H. Wessels et al. · Thrombosis and Haemostasis · 1995 · 655 citations

Medicine, Hematology, Clinical Biochemistry +13

Bleeding in carriers of hemophilia

Iris Plug, Eveline P. Mauser‐Bunschoten, Annette Bröcker‐Vriends et al. · Blood · 2006 · 369 citations · Full text

Medicine, Hematology, Hemostasis +7

The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII

Lisbeth J. M. Sjamsoedin, L. Heijnen, Eveline P. Mauser‐Bunschoten et al. · New England Journal of Medicine · 1981 · 308 citations

Medicine, Hematology, Internal Medicine +16

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

Kathelijn Fischer, Johanna G. van der Bom, Eveline P. Mauser‐Bunschoten et al. · Blood · 2002 · 257 citations

Medicine, Hematology, Transfusion Medicine +8

Prophylactic versus on‐demand treatment strategies for severe haemophilia: a comparison of costs and long‐term outcome

Kathelijn Fischer, Johanna G. van der Bom, P Molho et al. · Haemophilia · 2002 · 210 citations

Pharmacy, Hematology, Pharmacoeconomics +17